F. Léger
F. Léger publishes mostly in Oncology, Molecular Biology and Hematology, on topics such as Cancer therapeutics and mechanisms, Cancer Treatment and Pharmacology and Antibiotics Pharmacokinetics and Efficacy.
- World rank
- #3,283,525 of 7,710,434 ranked researchers
- Rank in France
- #138,714 of 324,115
- Works
- 15
- Citations
- 594
- Citations per work
- 39.6
What does F. Léger research?
F. Léger's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences958.2%
- Medicine958.2%
- Everything else427.8%
- Life Sciences214.0%
- 1Oncology23% of their works
- 2Molecular Biology14% of their works
- 3Hematology9% of their works
- 4Pediatrics, Perinatology and Child Health9% of their works
- 5Pharmacology9% of their works
- 6Transplantation7% of their works
Research topics
- Cancer therapeutics and mechanisms
- Cancer Treatment and Pharmacology
- Antibiotics Pharmacokinetics and Efficacy
- Hematopoietic Stem Cell Transplantation
- Neutropenia and Cancer Infections
- Chemotherapy-induced organ toxicity mitigation
- Renal Transplantation Outcomes and Treatments
- Oral and gingival health research
Which keywords describe F. Léger's research?
The keywords of their largest research topics: Chemotherapy, DNA, Topoisomerases, Antibiotic Pharmacokinetics, Chemotherapy-Induced Peripheral Neuropathy, Critically Ill Patients, Taxanes and Antimicrobial Agents.
- Drug-Induced
- Nephrotoxicity
- Hematopoietic Stem Cells
- Cisplatin
- Antimicrobial Agents
- Critically Ill Patients
- Antibiotic Pharmacokinetics
- DNA
- Chemotherapy
- Topoisomerases
- Chemotherapy-Induced Peripheral Neuropathy
- Taxanes
- Bone Marrow Niche
- Febrile Neutropenia
- Kidney Transplantation
- Renal Allograft
- Gingival Overgrowth
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Chemotherapy123 topics
- DNA61 topic
- Topoisomerases61 topic
- Antibiotic Pharmacokinetics41 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Critically Ill Patients41 topic
- Taxanes41 topic
- Antimicrobial Agents31 topic
- Bone Marrow Niche31 topic
- Cisplatin31 topic
- Febrile Neutropenia31 topic
- Hematopoietic Stem Cells31 topic
- Kidney Transplantation31 topic
- Nephrotoxicity31 topic
- Renal Allograft31 topic
- Drug-Induced21 topic
- Gingival Overgrowth21 topic
Where does F. Léger work?
F. Léger's main affiliation in the publication record is Institut Claudius Regaud, France.
How many publications and citations does F. Léger have?
OpenAlex counts 15 works and 594 citations for F. Léger, an h-index of 10, ranking #3,283,525 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named F. Léger
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about F. Léger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.